<DOC>
	<DOC>NCT01623401</DOC>
	<brief_summary>This is a Phase 1 open-label study in healthy volunteers who will receive oral 200 mg TR 701 FA once daily for 10 days and will include ophthalmologic and neurologic assessments.</brief_summary>
	<brief_title>A Phase 1, Open-Label, 10 Day Safety Study</brief_title>
	<detailed_description>This is a Phase 1 open-label study in healthy volunteers who will receive oral 200 mg TR 701 FA once daily for 10 days (Days 1 through 10) and undergo safety evaluations including ophthalmologic and neurologic assessments before (Screening or Day -1), 1 day after final study drug administration (Day 11 or earlier if a subject discontinues treatment), and 2 to 4 weeks after the last study drug administration (Late Follow-up Visit).</detailed_description>
	<mesh_term>Torezolid phosphate</mesh_term>
	<criteria>Healthy males and females ≥ 18 and ≤ 65 years of age with no clinically significant abnormalities identified by a detailed medical history Female subjects must be nonpregnant, nonlactating, and either postmenopausal for at least 2 years, surgically sterile for at least 90 days, abstinent, or agree to use contraception from 1 week prior to Day 1 until 30 days after leaving the study center. Male subjects must be surgically sterile, abstinent, or agree to use contraception from Day 1 until 30 days after leaving the study center BMI ≥ 18.0 kg/m2 and ≤ 35.0 kg/m2 Hypersensitivity to oxazolidinones or any component in the formulation History or current significant ophthalmologic or neurologic condition that would adversely affect the clinical assessments or confound the interpretation of the data (e.g., dense cataracts, macular degeneration, retinitis pigmentosa) Positive hepatitis B surface antigen, hepatitis C virus antibody, or human immunodeficiency virus antibody test result Known genetic condition related to mitochondrial disease or dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>